Pharming Group (OTCMKTS:PHGUF) Short Interest Update

Pharming Group (OTCMKTS:PHGUF - Get Free Report) was the target of a significant drop in short interest during the month of March. As of March 31st, there was short interest totalling 3,342,300 shares, a drop of 30.8% from the March 15th total of 4,828,600 shares. Based on an average daily volume of 0 shares, the short-interest ratio is presently ∞ days. Currently, 0.5% of the company's stock are sold short.

Pharming Group Stock Up 13.1 %

Pharming Group stock traded up $0.10 during midday trading on Wednesday, hitting $0.89. The stock had a trading volume of 100 shares, compared to its average volume of 18,240. The business has a fifty day moving average price of $0.89 and a 200 day moving average price of $0.87. Pharming Group has a 12 month low of $0.75 and a 12 month high of $1.07. The stock has a market cap of $599.40 million, a P/E ratio of -44.66 and a beta of 0.91. The company has a current ratio of 3.53, a quick ratio of 2.76 and a debt-to-equity ratio of 0.53.

Pharming Group Company Profile

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K? inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome.